International Money Express, Inc. IMXIW 深 滬

Western Union declares $0.235 dividend

Western Union (NYSE:WU) declares $0.235/share quarterly dividend, in line with previous. Forward yield 11.05% Payable Sept. 30; for shareholders of record Sept. 16; ex-div Sept. 16. See WU Dividend Sc...

08-29 12:44

International Money Express Enters Strategic Partnership With Zeepay To Leverage Intermex's Wire-As-A-service Platform To Better Serve African Communities Abroad

International Money Express, Inc. (NASDAQ:IMXI) ("Intermex" or the "Company"), a leading money remittance provider to Latin America and the Caribbean, today announced a new strategic partnership with Zeepay, a rapidly

08-26 20:12

Western Union Acquires Intermex for $500 Million

Western Union ( ($WU) ) has issued an update. On August 10, 2025, Western Union...

08-11 20:29

Reported Sunday, Western Union To Acquire International Money Express In $500M All-Cash Deal At $16 Per Share

This acquisition strengthens Western Union's retail offering in the U.S., expands market coverage in high potential geographies, and is expected to accelerate digital new customer acquisition. Intermex's deep market

08-11 15:33

西联汇款将以5亿美元收购International Money Express

西联汇款(Western Union)将以约5亿美元的总股本和企业价值收购International Money Express (简称Intermex)。这家...

08-11 08:49

西聯匯款將以5億美元現金收購International Money Express

08-11 08:05

International Money Express Chief Legal Officer Resigns

International Money Express ( ($IMXI) ) just unveiled an announcement. On July ...

08-01 05:16

Intermex and the New York Red Bulls Join Forces to Bring Financial Services to Northeastern Communities Through the Shared Passion for Soccer

International Money Express (Intermex) has officially partnered with the New York Red Bulls to strengthen ties with the Latino community in the northeast, leveraging soccer as a unifying force. This collaboration focuses on in-stadium activations, community outreach, and cultural initiatives reflecting the passion and identity of Latino families. Both organizations aim to enhance customer engagement and deliver exceptional experiences.

06-17 12:00

Immix Biopharma Announces Primary Endpoint Met in positive NXC-201 Interim Results Presented at ASCO, Enabling Path to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

Immix Biopharma's NXC-201 met its primary endpoint in the Phase 1/2 NEXICART-2 trial for relapsed/refractory AL Amyloidosis, achieving a 70% complete response rate (7/10 patients) with no relapses or safety signals. The company plans a Biologics License Application (BLA) submission to the FDA. A Key Opinion Leader (KOL) event to discuss the results will be held on June 3, 2025.

06-03 18:55

International Money Express shares are trading lower after the company reported worse-than-expected Q1 financial results and cut its FY25 guidance.

International Money Express shares are trading lower after the company reported...

05-07 21:03